MDxHealth is a precision diagnostics company that offers urologic solutions globally. Its prostate cancer genomic testing solutions, SelectMDx and ConfirmMDx, provide physicians with a non-invasive and epigenetic test to identify clinically prostate cancer while minimizing the use of invasive procedures. The company was formerly known as OncoMethylome Sciences SA and is headquartered in Herstal, Belgium.